Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been confirmed by a tissue test (biopsy) to have invasive breast cancer in one breast only
- People for whom radiation therapy has been recommended
- People for whom chemotherapy before surgery (which may include antibody treatment or other targeted therapies) has been recommended, in line with standard medical guidelines
- People who are female
- People who have signed the official consent form for the trial
- People with any hormone receptor or HER2 status (no restrictions apply to these test results)
- People with any tumour grade (G1, G2, or G3)
- People aged 18 or older at the time of signing the consent form
- People with a general health/activity level rated at 2 or below on a standard medical scale (confirm with trial site)
- People with no existing health conditions that would prevent treatment
Who may not be able to join:
- People whose only planned pre-surgery treatment is hormone therapy (without chemotherapy)
- People who have breast cancer in both breasts
- People who are pregnant or breastfeeding
- People who have previously had radiation therapy to the chest area
- People who have a connective tissue disease, such as rheumatoid arthritis or a condition involving blood vessel inflammation (thromboangiitis obliterans)
- People who have an existing, symptomatic chronic lung condition, such as lung scarring (fibrosis), dust-related lung disease, severe lung conditions caused by allergies (such as farmer's lung), severe emphysema, or advanced COPD
- People with certain heart conditions, including symptomatic coronary heart disease, a previous heart attack, heart failure of a certain severity, or who have a pacemaker or implanted defibrillator (confirm severity levels with trial site)
- People who have or have had another cancer, except for a specific type of skin cancer (basalioma) or non-invasive cancers that have fully cleared
- People whose cancer has spread to distant parts of the body (metastasis)
- People who have nerve problems affecting the arm on the same side as the affected breast
- People who have shoulder stiffness on the same side as the breast cancer, regardless of the cause (for example, following an injury)
- People who have moderate to severe arm swelling (lymphoedema rated grade II or higher) on the same side as the breast cancer
- People with other medical conditions that would prevent them from safely receiving pre-surgery radiation therapy, including an expectation that they would not be able to follow the treatment plan
- People who are male
- People who have already had an assessment of how their cancer responds to chemotherapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christiane M Prof., MD Prof., Bielefeld University
Phone: +495215812901
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
disease free survival (DFS):
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.